Clinical Evaluation of the Cochlear Nucleus(R) CI532 Cochlear Implant in Adults
Clinical Evaluation of the Cochlear Nucleus(R) CI532 Cochlear Implant in Adults
The purpose of this study is to gather long-term data on the FDA approved CI532 cochlear implant, and CP1000 (Nucleus 7) sound processor
Appropriate candidates will receive a CI532 cochlear implant and be fit with the CP1000 sound processor. Imaging will be completed pre-op, intra-op, and post-op to assess implant location. Speech perception testing as well as subjective questionnaires will be administered over 12 months.
Inclusion Criteria:
Exclusion Criteria: